Investor Centre
Medigard was established in 1999 and listed on the Australian Stock Exchange in February 2004. The directors and executives have extensive business and commercialisation experience at senior levels and are supported by an award winning design and production team.
PUBLICATIONS, ANNOUNCEMENTS & REPORTS
AnnUAL rEporT 2009
To read or download the Medigard Annual report 2009 please click here.
AnnUAL rEporT 2008
To read or download the Medigard Annual report 2008 please click here.
AnnUAL rEporT 2007
To read or download the Medigard Annual report 2007 please click here.
AnnUAL rEporT 2006
To read or download the Medigard Annual report 2006 please click here.
AnnUAL rEporT 2005
To read or download the Medigard Annual report 2005 please click here.
AnnUAL rEporT 2004
To read or download the Medigard Annual report 2004 please click here.
ANNOUNCEMENTS
AUG 2010
Boardroom Radio Announcement 20th Aug 2010
AUG 2010
Investor Presentations
AUG 2010
Despatch of Prospectus and Letter to Shareholders
AUG 2010
Letter to Shareholders
AUG 2010
Supplementary Prospectus
AUG 2010
Market Announcement
AUG 2010
Boardroom Radio Announcement 3rd Aug 2010
JUL 2010
Medigard letter to Shareholders
JUL 2010
Medigard announces Rights Issue to support US expansion
MAY 2010
Medigard expands into the US
MAY 2010
Replacement and updated appendix 3B
APR 2010
Quarterly report for the period ending 31 March, 2010
APR 2010
Application for quotation of additional securities and agreement
APR 2010
Medigard 3mL safety retractable syringe - clinical trials results
MAR 2010
Application for quotation of additional securities and agreement
MAR 2010
Marketing - retractable syringe product evaluation
FEB 2010
Half yearly announcement
JAN 2010
Quarterly report for the period ending 31 December, 2009
DEC 2009
Medigard signs US manufacturer
NOV 2009
Confirmation of resolutions passed at annual general meeting
NOV 2009
Annual general meeting presentations
SEP 2009
Quarterly report for entities admitted on the basis of commitments
SEP 2009
Annual statutory accounts year ended 30 June, 2009
SEP 2009
Letter to shareholders
REPORTS
AUG 2009
Results for announcement
JUN 2009
Quarterly report
JUN 2009
Expiry of options
APR 2009
Change of director’s interest
APR 2009
Change of director’s interest
APR 2009
Change of director’s interest
APR 2009
Change of director’s interest
APR 2009
Loyalty bonus options
APR 2009
Prospectus lodges with ASIC
APR 2009
Completion of SPP
MAR 2009
Quarterly report
Presentation AUG 2010
To read or download Medigard’s AUG 2010 presentation including product overviews, information on the medical device market and opportunities available please click here.
Medigard will offer existing shareholders 74,046,091 new shares at an issue price of 6.5 cents. As part of the offer, each new share will have an attached option, exercisable at 9.5 cents on or before 30 June 2011. The offer opens on 10 August 2010 and closes on 25 August 2010. Trading of Rights will commence on the ASX on 30 July 2010 and cease on 18 August 2010. New shares are expected to commence trading on 2 September 2010. To download the prospectus click here.
To view Medigard’s (MGZ) current share price.Click here